{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:06:46Z","timestamp":1762506406854},"reference-count":4,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2013,9,17]],"date-time":"2013-09-17T00:00:00Z","timestamp":1379376000000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychogeriatrics"],"published-print":{"date-parts":[[2013,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Memantine is an <jats:styled-content style=\"fixed-case\">N<\/jats:styled-content>\u2010methyl\u2010<jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>\u2010aspartate glutamate receptor antagonist that may improve cognitive functions in patients with <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>lzheimer's disease. It is predominantly excreted unchanged via the kidneys, and patients with decreased creatinine clearance must be treated with lower doses of memantine. However, it is unclear whether memantine itself can lead to renal dysfunction and\/or hyperkalaemia. We report a patient with renal impairment and hyperkalaemia possibly associated with memantine administration.<\/jats:p>","DOI":"10.1111\/psyg.12022","type":"journal-article","created":{"date-parts":[[2014,8,22]],"date-time":"2014-08-22T01:33:40Z","timestamp":1408671220000},"page":"180-181","source":"Crossref","is-referenced-by-count":5,"title":["Memantine\u2010associated hyperkalaemia in a patient with <scp>A<\/scp>lzheimer's disease"],"prefix":"10.1111","volume":"13","author":[{"given":"Tatsuo","family":"Tsukamoto","sequence":"first","affiliation":[{"name":"Department of Neuropsychiatry Kurume University School of Medicine  Kurume Japan"},{"name":"Department of Psychiatry St. Maria Hospital  Kurume Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetaka","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry Kurume University School of Medicine  Kurume Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohisa","family":"Uchimura","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry Kurume University School of Medicine  Kurume Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,9,17]]},"reference":[{"key":"e_1_2_2_2_1","doi-asserted-by":"publisher","DOI":"10.2165\/11201020-000000000-00000"},{"key":"e_1_2_2_3_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-112-8-568"},{"key":"e_1_2_2_4_1","volume-title":"Harrison's Principles of Internal Medicine","author":"Longo D","year":"2001"},{"key":"e_1_2_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.10.005"}],"container-title":["Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fpsyg.12022","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/psyg.12022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T19:40:53Z","timestamp":1696016453000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/psyg.12022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":4,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.1111\/psyg.12022"],"URL":"https:\/\/doi.org\/10.1111\/psyg.12022","archive":["Portico"],"relation":{},"ISSN":["1346-3500","1479-8301"],"issn-type":[{"value":"1346-3500","type":"print"},{"value":"1479-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}